[go: up one dir, main page]

MX2019007771A - Composiciones alimenticias para mascotas. - Google Patents

Composiciones alimenticias para mascotas.

Info

Publication number
MX2019007771A
MX2019007771A MX2019007771A MX2019007771A MX2019007771A MX 2019007771 A MX2019007771 A MX 2019007771A MX 2019007771 A MX2019007771 A MX 2019007771A MX 2019007771 A MX2019007771 A MX 2019007771A MX 2019007771 A MX2019007771 A MX 2019007771A
Authority
MX
Mexico
Prior art keywords
pets
food compositions
reduce
acid
methods
Prior art date
Application number
MX2019007771A
Other languages
English (en)
Other versions
MX383445B (es
Inventor
Brockman Jeffrey
Edward Jewell Dennis
Scherl Dale
Davidson Stephen
Golder Christina
Avila Albert
Original Assignee
Hills Pet Nutritrion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57799883&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2019007771(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hills Pet Nutritrion Inc filed Critical Hills Pet Nutritrion Inc
Publication of MX2019007771A publication Critical patent/MX2019007771A/es
Publication of MX383445B publication Critical patent/MX383445B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/348—Urinary tract infections

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Fodder In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Feed For Specific Animals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

En la presente descripción se describen métodos y composiciones para: - entre otros - reducir la densidad relativa de la orina y reducir el índice de riesgo de oxalato de calcio en felinos. En particular, las dietas y métodos que usan ciertas cantidades y relaciones de ácido araquidónico (AA), ácido eicosapentaenoico (EPA) y ácido docosahexaenoico (DHA).
MX2019007771A 2016-12-27 2016-12-27 Composiciones alimenticias para mascotas. MX383445B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/068651 WO2018125029A1 (en) 2016-12-27 2016-12-27 Pet food compositions

Publications (2)

Publication Number Publication Date
MX2019007771A true MX2019007771A (es) 2019-09-09
MX383445B MX383445B (es) 2025-03-13

Family

ID=57799883

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019007771A MX383445B (es) 2016-12-27 2016-12-27 Composiciones alimenticias para mascotas.
MX2019007774A MX386161B (es) 2016-12-27 2017-12-08 Composición alimenticia para mascotas que comprende ácidos grasos poliinsaturados.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019007774A MX386161B (es) 2016-12-27 2017-12-08 Composición alimenticia para mascotas que comprende ácidos grasos poliinsaturados.

Country Status (11)

Country Link
US (2) US11234452B2 (es)
EP (2) EP3547845B1 (es)
JP (3) JP2020503036A (es)
CN (1) CN110121268B (es)
AU (2) AU2016433750B2 (es)
BR (1) BR112019013188B1 (es)
CA (2) CA3040675C (es)
MX (2) MX383445B (es)
RU (1) RU2727670C1 (es)
WO (2) WO2018125029A1 (es)
ZA (1) ZA201904001B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11606960B2 (en) * 2018-08-31 2023-03-21 The Scoop Pet Food Manufacturing Llc Food compositions and methods for preventing copper-associated hepatopathies
EP3899045B1 (en) 2019-01-25 2025-09-10 Hill's Pet Nutrition, Inc. Methods for identifying a companion animal susceptible to treatment that reduces the risk of stone formation and use of compositions for reducing such risk
WO2020160216A1 (en) * 2019-02-01 2020-08-06 Mars, Incorporated Feline food composition
AU2019479586B2 (en) * 2019-12-16 2024-08-08 Hill's Pet Nutrition, Inc. Methods, kits and compositions for diagnosing and treating renal disease
AU2019478841B2 (en) * 2019-12-18 2024-10-10 Hill's Pet Nutrition, Inc. Methods for identifying a companion animal at risk of calcium oxalate stone formation and treatments and compositions for reducing the risk
MX2022012232A (es) * 2020-04-06 2022-10-27 Hills Pet Nutrition Inc Composiciones alimenticias para mascotas.
CN116322357A (zh) * 2020-10-14 2023-06-23 希尔氏宠物营养品公司 宠物食品组合物
CN112273555A (zh) * 2020-10-28 2021-01-29 上海耐威克宠物用品有限公司 一种猫条以及该猫条的制备方法
CN116709927A (zh) * 2020-12-22 2023-09-05 希尔氏宠物营养品公司 用于评估和治疗间质性膀胱炎的方法、试剂盒和组合物
CN112802544A (zh) * 2021-03-12 2021-05-14 杭州度安医学检验实验室有限公司 一种基于机器学习和代谢组学预测泌尿结石的系统
KR102841283B1 (ko) * 2024-12-10 2025-08-01 (주)펫퍼블릭 요로결석 예방을 위한 반려동물용 기능성 간식의 제조 방법

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788232A (fr) 1971-09-03 1973-02-28 Merck Patent Gmbh Agent et procede pour la determination du calcium
JPS5436996A (en) * 1977-08-29 1979-03-19 Motoshi Kitamura Calcium analytical method
US4183729A (en) 1978-02-27 1980-01-15 University Patents, Inc. Apparatus and method for determining crystallization properties of urine
IL59982A (en) 1980-05-02 1982-12-31 Yissum Res Dev Co Method and kit for diagnosing a patient's proneness to develop calcium oxalate kidney stones
US4303896A (en) 1980-05-21 1981-12-01 The Babcock & Wilcox Company Wide range data cable equalizer
JPS57154058A (en) 1981-03-20 1982-09-22 Wako Pure Chem Ind Ltd Determining method of calcium
ES2003686A6 (es) 1987-02-18 1988-11-01 Univ De Las Illes Balears E In Metodo para detectar la formacion de cristales de oxalato calcico en una muestra de orina en presencia de un inhibidor de la litiasis renal
JPH06104008B2 (ja) 1988-06-28 1994-12-21 株式会社クボタ 施肥・播種装置
SU1629846A1 (ru) 1988-07-19 1991-02-23 Украинский Институт Усовершенствования Врачей Способ определени кристаллоингибирующей активности мочи
IL89447A0 (en) 1989-03-02 1989-09-10 Galai Lab Ltd Analytical clinical method and device for carrying out such method
US5366899A (en) 1990-08-08 1994-11-22 Vladimir N. Shabalin Methods of diagnosing complicated urolithiasis and predicting urolithiasis
JP2634759B2 (ja) 1993-08-02 1997-07-30 前田 浩志 愛玩動物尿症病の体外診断方法
CA2147109A1 (en) 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses
JP3524968B2 (ja) 1994-10-04 2004-05-10 株式会社エスアールエル 生体結石中のシュウ酸カルシウム・一水化物とシュウ酸カルシウム・二水化物の赤外分光分析による定量
US6027939A (en) 1996-03-08 2000-02-22 Universidad De Las Islas Baleares Process for evaluating the global capacity of urine to form chalky renal calculus, and corresponding kit
IL126881A0 (en) 1998-11-04 1999-09-22 Dan Gottlieb Image analysis of urine
US6071544A (en) 1999-04-01 2000-06-06 The Iams Company Dietary compositions and method for promoting healthy weight loss cats
AT409685B (de) 1999-07-22 2002-10-25 Egston Eggenburger Syst Elektr Elektrisches/elektronisches gerät
US6946488B2 (en) 2000-05-01 2005-09-20 The Iams Company Pet food composition for reducing inflammatory response in cats
ES2284644T3 (es) * 2000-05-01 2007-11-16 The Iams Company Composicion alimenticia para animales de compañia para reducir la respuesta inflamatoria en gatos.
WO2003103579A2 (en) 2002-06-05 2003-12-18 Transform Pharmaceuticals, Inc. High-throughput methods and systems for screening of compounds to treat/prevent kidney disorders
CN1570635A (zh) 2003-07-17 2005-01-26 赵青华 尿钙生化检测液
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
EP1907839B1 (en) 2005-07-12 2013-08-21 Hill's Pet Nutrition, Inc. Methods for predicting urine ph
JP2007116977A (ja) 2005-10-27 2007-05-17 Toyobo Co Ltd 他測定項目への影響低減方法
AU2007211625B2 (en) 2006-02-01 2012-08-23 Nestec S.A. Nutritional system and methods for increasing longevity
US20100236975A1 (en) 2006-03-27 2010-09-23 Hill's Pet Nutrition, Inc. Methods for predicting oxalate and struvite stone formation in animals
CN100434913C (zh) 2006-07-25 2008-11-19 暨南大学 基于五电极法的尿路结石智能诊断仪
EP2197292A1 (en) 2007-12-21 2010-06-23 Hill's Pet Nutrition Inc. Pet food composition
AU2010276259B2 (en) * 2009-07-21 2013-04-18 Hill's Pet Nutrition, Inc. Companion animal nutrition system
ES1071520Y (es) 2009-12-14 2010-06-04 Univ Illes Balears Dispositivo portatil de analisis del ph de la orina
WO2013017725A1 (es) 2011-08-01 2013-02-07 Universitat Autonoma De Barcelona Uso de redes neuronales artificiales para la detección de la formación de piedras en los riñones y para establecer la composición de dichas piedras
US11077238B2 (en) 2013-06-07 2021-08-03 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis
EP3461911B1 (en) * 2013-11-12 2021-01-06 Hill's Pet Nutrition, Inc. Improving the level of hydration in a cat
TWI541504B (zh) 2014-01-20 2016-07-11 國立陽明大學 尿晶體檢測系統及方法
US10285961B2 (en) * 2014-02-06 2019-05-14 University Of Houston System Organic acids as agents to dissolve calcium minerals in pathological calcification and uses thereof
US9492491B1 (en) * 2015-09-04 2016-11-15 Kidney Stone Laboratories, Inc. Compositions and methods to inhibit kidney stone growth
GB201617564D0 (en) * 2016-10-17 2016-11-30 Agency For Science Technology And Research And National University Of Singapore And Singapore Health Anti-p53 antibodies
EP3557249A4 (en) 2016-12-19 2020-09-30 Yukashikado Inc. URINE TESTING DEVICE AND URINE TESTING METHOD
JP6639537B2 (ja) 2018-02-13 2020-02-05 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ネコの水和レベルの向上

Also Published As

Publication number Publication date
US20200120956A1 (en) 2020-04-23
BR112019013188B1 (pt) 2022-12-27
MX383445B (es) 2025-03-13
US11330830B2 (en) 2022-05-17
JP7377835B2 (ja) 2023-11-10
MX2019007774A (es) 2019-09-09
RU2727670C1 (ru) 2020-07-22
JP6817450B2 (ja) 2021-01-20
AU2017387792A1 (en) 2019-07-11
ZA201904001B (en) 2022-12-21
AU2017387792B2 (en) 2020-12-10
CA3040675C (en) 2024-02-20
JP2021129600A (ja) 2021-09-09
US20200284812A1 (en) 2020-09-10
EP3547845A1 (en) 2019-10-09
CA3040524A1 (en) 2018-07-05
JP2020514716A (ja) 2020-05-21
CN110121268B (zh) 2023-01-31
BR112019013188A2 (pt) 2019-12-10
CN110121268A (zh) 2019-08-13
MX386161B (es) 2025-03-18
EP3528870A1 (en) 2019-08-28
WO2018125539A1 (en) 2018-07-05
AU2016433750A1 (en) 2019-07-11
EP3547845B1 (en) 2023-03-01
AU2016433750B2 (en) 2020-04-09
US11234452B2 (en) 2022-02-01
JP2020503036A (ja) 2020-01-30
CA3040675A1 (en) 2018-07-05
WO2018125029A1 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
MX2019007771A (es) Composiciones alimenticias para mascotas.
MX2016008270A (es) Lipido que comprende acidos grasos poliinsaturados de cadena larga.
EA201400152A1 (ru) Микроорганизмы, продуцирующие эйкозапентаеновую кислоту, композиции, содержащие жирные кислоты, и способы их получения и применения
ES2666322T3 (es) Composiciones farmacéuticas para el tratamiento de trastornos musculares
MX2017016819A (es) Composiciones antimicrobianas y sus usos.
MX383753B (es) Modulación de la expresión similar a la angiopoyetina tipo 3.
CY1122248T1 (el) Μιγμα λιπαρων οξεων προς χρηση στη θεραπευτικη αγωγη φλεγμονωδων παθολογιων
MX372724B (es) Formulaciones de acido eicosapentaenoico (epa).
EA201690483A1 (ru) Композиция среднецепочечных жирных кислот и корм с добавлением композиции
CL2020001972A1 (es) Ingredientes de pienso que comprenden células microbianas lisadas. (divisional solicitud 201803797)
WO2016040570A3 (en) Dietary emulsion formulations and methods for using the same
CL2015001138A1 (es) Retiro de componentes indeseados de las composiciones de aceite
MX2017005756A (es) Producto alimenticio para mascotas extruido.
BR112015026207A2 (pt) uso de uma preparação na fabricação de uma composição nutricional, composição nutricional, uso de uma composição nutricional, uso de uma composição, composição, e método para tratamento ou fornecimento de gerenciamento nutricional de pacientes com hiperfenilalaninemia e/ou pacientes com fenilcetonúria
CO2017001088A2 (es) Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas
CL2016001453A1 (es) Composiciones sintéticas de leche que comprenden ácidos grasos poliinsaturados (pufa) para promover el establecimiento saludable de la función cognitiva en infantes varones y hembras y niños y niñas.
MX2018004128A (es) Composiciones de aceite y metodos para elaborarlas.
CL2017001472A1 (es) Composiciones y métodos que comprenden triglicéridos de cadena media para el tratamiento de la epilepsia.
CL2019001708A1 (es) Métodos para producir biomasa rica en dha, ácido palmítico y proteínas con un microorganismo eucariota.
BR112014017048A8 (pt) emulsão orgânica compreendendo dha e epa
MX2020004739A (es) Composiciones que comprenden acidos grasos de cadena media y poliinsaturados omega-3.
BR112017010431A2 (pt) método para aumentar os níveis de omega-3-s em carne
CL2018002946A1 (es) Métodos para elaborar formulaciones nutricionales.
CL2017002648A1 (es) Composición saborizante para alimentos de animales
WO2015013678A3 (en) Stable fatty acid compositions